Nick Bayhi, PhD
CEO
AddGraft Therapeutics
Dr. Bayhi is the CEO of AddGraft Therapeutics, a spinout of the University of Chicago. Dr. Bayhi brings over 15 years in protein and cell R&D and 3 years of venture capital/creation experience to this role, bridging the gap between scientific rigor and business acumen.
Sessions
-
23-Jun-20265BAddGraft Therapeutics
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}